IIM
RVMD icon

INTECH Investment Management’s Revolution Medicines RVMD Stock Holding History

INTECH Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
+5,384
New +$786K 0.01% 1027
2025
Q2 		– Sell
-107,628
Closed -$3.81M – 2645
2025
Q1 		$3.81M Buy
107,628
+35,300
+49% +$1.43M 0.04% 419
2024
Q4 		$3.16M Buy
72,328
+34,634
+92% +$1.75M 0.03% 473
2024
Q3 		$1.71M Buy
+37,694
New +$1.64M 0.02% 544

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

INTECH Investment Management's RVMD Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 5,384 shares worth $1.01M. The stake represents 0.01% of the portfolio and ranks #1027 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in RVMD as recently as Q1 2025.

INTECH Investment Management first reported a position in RVMD in Q3 2024 and has held it in 4 quarters since. The position peaked at $3.81M in Q1 2025. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • INTECH Investment Management held 5,384 shares of Revolution Medicines worth $1.01M as of Q2 2026.
  • Revolution Medicines was a new INTECH Investment Management position in Q2 2026.
  • Revolution Medicines made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1027 holding.
  • INTECH Investment Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 4 quarters since.
  • INTECH Investment Management's Revolution Medicines position peaked at $3.81M in Q1 2025.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.